Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06135883
Other study ID # KBU-EMEKLIOGLU-001
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 20, 2023
Est. completion date August 20, 2023

Study information

Verified date November 2023
Source Karabuk University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Aim of this study is to investigate and statistically reveal the prevalence and awareness of folic acid usage in pregnant women who have at least one of the risk factors for neural tube defects, to express the level of knowledge of the determined population on this subject and to present ideas to increase awareness in the society.


Recruitment information / eligibility

Status Completed
Enrollment 267
Est. completion date August 20, 2023
Est. primary completion date August 20, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - over 18 years - Under 45 years of age - Having at least one of the risk factors for neural tube defects (family history, MTHFR gene mutation, birth defect with aneuploidy, history of GDM or known DM) for Case Group. - Singleton pregnant women Exclusion Criteria: - under 18 years old - Above 45 years old - Multiple pregnancies

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Prof. Dr. Cemil Tascioglu City Hospital Istanbul Sisli

Sponsors (1)

Lead Sponsor Collaborator
Karabuk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary High awareness level for high-risk pregnant women Pregnant women with at least one risk factor for neural tube defects have statistically higher folic acid use and awareness than control group pregnant women. up to 12 weeks
Primary Low awareness level for society, regardless of the risk situation Low folic acid knowledge and awareness in the sample groups, regardless of risk status up to 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT05883761 - Birth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment
Terminated NCT04140669 - Automated Myocardial Performance Index Using Samsung HERA W10
Completed NCT01244399 - Influence of "Espresso" on Adsorption of Myo-inositol
Recruiting NCT03856034 - Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele N/A
Recruiting NCT04362592 - In-Utero Endoscopic Correction of Spina Bifida N/A
Recruiting NCT05672849 - Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases N/A
Active, not recruiting NCT03936322 - Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study N/A
Completed NCT01743196 - Folate Metabolism in Normal Weight and Obese Women of Child-bearing Age N/A
Active, not recruiting NCT03090633 - Fetoscopic Repair of Isolated Fetal Spina Bifida N/A
Completed NCT01392989 - Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders Phase 2
Completed NCT06174883 - Salt-FA to Increase Folate Levels
Completed NCT05935631 - Feasibility, Acceptability and Directional Signal Effect on Blood Folate Levels of Iodized Salt Fortified With Folic Acid: Clinical Study N/A
Recruiting NCT03315637 - Fetal Endoscopic Surgery for Spina Bifida N/A
Completed NCT00394862 - Efficacy of Weekly Versus Daily Folic Acid Supplementation N/A
Completed NCT04135274 - Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?
Active, not recruiting NCT04760509 - Short- Term Follow up Of Neonates Born With Neural Tube Defect
Active, not recruiting NCT03794011 - Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study Phase 1
Recruiting NCT04523233 - Metals/Vitamins Levels in NTD
Recruiting NCT01253746 - Genetics of Neural Tube Defects N/A
Completed NCT00468481 - Efficacy and Safety Study for an Oral Contraceptive Containing Folate Phase 3